NPPA releases draft calculation sheet with ceiling price of six scheduled formulations: Gireesh Babu, New Delhi Monday, ...
The European Medicines Agency’s (EMA) human medicines committee (CHMP) has recommended extending the therapeutic indication ...
A randomized study demonstrated that dietary nursing interventions affect nutritional status, immune function, and quality of life for patients with GI cancer receiving chemotherapy.
People in the rapid-decliners group saw a robust rise in post-vaccination IgG (S) antibody titers, followed by a steep decline. Antibody titers dropped below 10 AU/mL in 56% of them 1 year after ...
TipRanks on MSN
Celldex announces new barzolvolimab data at EADV congress
Celldex (CLDX) announced new data demonstrating rapid and strong efficacy regardless of baseline immunoglobulin E levels in patients with chronic ...
Data reinforce that mast cells are important drivers of CSU regardless of the underlying endotype and are consistent with the novel mechanism of action of barzolvolimab. Barzolvolimab is a promising ...
Health and Me on MSN
Rabies Deaths in India: Why People Still Die Despite Effective Vaccines
Recently, reports have emerged of people dying of rabies despite being vaccinated. Doctors, however, caution that the problem ...
Falling vaccination rates among U.S. children may make local outbreaks of highly contagious measles cases increasingly common -- and that's bringing parents into clinicians' offices with plenty of ...
A nasal allergy test showed strong diagnostic performance, with sensitivity exceeding 75% and specificity approaching 90% for ...
Travere Therapeutics, Inc. is rated Buy with FILSPARI’s robust growth, FDA approval, and key milestones ahead. Click here to ...
Technicians check blood products at Pacific Shuanglin Bio-pharmacy Co Ltd's factory. [Photo provided to chinadaily.com.cn] In ...
Vyvgart and robust R&D, balanced by risks and diversification potential. Read here for more analysis of ARGX stock.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results